Fred W. Blakeslee
Executive VP & General CounselMr. Fred W. Blakeslee II is a Partner of the Corporate Department in the Chicago Office at Mayer Brown LLP. He serves as Executive VP & General Counsel since October 16, 2025 at Lakefront Biotherapeutics NV (formerly known as Galapagos NV). He joined Galapagos since October 16, 2025. Mr. Blakeslee was an Associate in the Private Equity Practice at Mayer Brown LLP. His practice focuses primarily on private equity leveraged buyouts, mergers, acquisitions, divestitures and growth equity investments and he has assisted with various transactions for numerous Private Equity firms. He began his career at Kirkland & Ellis LLP and later held senior roles at leading law firms, advising on private equity, corporate and securities transactions across the biopharmaceutical and other industries. Mr. Blakeslee holds JD, cum laude from Northwestern University School of Law in 2002 and BS in Mathematics and BA in Political Science, magna cum laude from The Ohio State University in 1999.
Positions
- Company NameLakefront Biotherapeutics NVStock CodeLKFTPositionExecutive VP & General CounselColleagues
- HOHenry O. GosebruchCEO & Executive Director
- GSGino SantiniIndependent Non-Executive Chairman
- ALAaron L. CoxChief Financial Officer
- CCChristina CarlsonChief Operating Officer
- GSGlenn SchulmanHead of Investor Relations
- JVJane Veronica GriffithsNon-Executive Independent Director
- DADawn A. SvoronosNon-Executive Independent Director
- NGNeil G. JohnstonNon-Executive Independent Director
